Pneumococcal Vaccine Global Market Opportunities And Strategies To 2034

Published Sep 18, 2025

Length 338 Pages

SKU # BRC20410908

Description

Pneumococcal Vaccine Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pneumococcal vaccine market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for pneumococcal vaccine? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pneumococcal vaccine market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider pneumococcal vaccine market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by route of administration, by distribution channel and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by route of administration, by distribution channel and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for pneumococcal vaccine providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Product Type: Pneumococcal Conjugate Vaccine (PCVs); Pneumococcal Polysaccharide Vaccine (PPV)

2) By Route Of Administration: Intramuscular; Subcutaneous

3) By Distribution Channel: Pharmacies; Community Clinics; Public Health Agencies; Other Distribution Channels

4) By End User: Pediatrics; Adults

Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Serum Institute of India Pvt. Ltd.; Walvax Biotechnology Co. Ltd.

Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pneumococcal vaccine indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Pneumococcal Vaccine – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Pneumococcal Vaccine Market Definition And Segmentations; 6.4 Market Segmentation By Product Type; 6.4.1 Pneumococcal Conjugate Vaccine (PCVs); 6.4.2 Pneumococcal Polysaccharide Vaccine (PPV); 6.5 Market Segmentation By Route of Administration; 6.5.1 Intramuscular; 6.5.2 Subcutaneous; 6.6 Market Segmentation By Distribution Channel; 6.6.1 Pharmacies; 6.6.2 Community Clinics; 6.6.3 Public Health Agencies; 6.6.4 Other Distribution Channels; 6.7 Market Segmentation By End User; 6.7.1 Pediatrics; 6.7.2 Adults
7 Major Market Trends: 7.1 Innovative Pneumococcal Vaccine Enhances Pediatric Immunization By Targeting Local Disease Burden; 7.2 Innovative Conjugate Vaccines Aim To Bridge Global Immunization Gaps; 7.3 Strategic Collaborations Accelerate Pneumococcal Vaccine Access; 7.4 New Investment Wave Supports Scalable Pneumococcal Immunization; 7.5 Advancing Adult Immunization Through Serotype-Specific Vaccines; 7.6 Advances In Conjugate Vaccine Technology Improve Adult Immunity
8 Pneumococcal Vaccine Growth Analysis And Strategic Analysis Framework: 8.1 Pneumococcal Vaccine PESTEL Analysis; 8.1.1 Political; 8.1.2 Economic; 8.1.3 Social; 8.1.4 Technological; 8.1.5 Environmental; 8.1.6 Legal; 8.2 Analysis Of End User (B2B and B2C); 8.2.1 Pediatrics; 8.2.2 Adults; 8.3 Pneumococcal Vaccine Market Growth Rate Analysis; 8.4 Global Historic Market Growth, 2019 – 2024, Value ($ Million); 8.4.1 Market Drivers 2019 – 2024; 8.4.2 Market Restraints 2019 – 2024; 8.5 Global Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million); 8.6 Forecast Growth Contributors/Factors; 8.6.1 Quantitative Growth Contributors; 8.6.2 Drivers; 8.6.3 Restraints; 8.7 Global Pneumococcal Vaccine Total Addressable Market (TAM)
9 Pneumococcal Vaccine Market Segmentation: 9.1 Global Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.2 Global Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.3 Global Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.4 Global Pneumococcal Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.5 Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Conjugate Vaccines (PCVs), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.6 Global Pneumococcal Vaccine Market, Sub-Segmentation Of Pneumococcal Polysaccharide Vaccine (PPV), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Pneumococcal Vaccine Market, Regional and Country Analysis: 10.1 Pneumococcal Vaccine Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 10.2 Pneumococcal Vaccine Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market: 11.1 Summary; 11.2 Market Overview; 11.2.1 Region Information; 11.2.2 Market Information; 11.2.3 Background Information; 11.2.4 Government Initiatives; 11.2.5 Regulations; 11.2.6 Regulatory Bodies; 11.2.7 Major Associations; 11.2.8 Taxes Levied; 11.2.9 Corporate Tax Structure; 11.2.10 Investments; 11.2.11 Major Companies; 11.3 Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.4 Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.5 Asia-Pacific Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.6 Asia-Pacific Pneumococcal Vaccine Market: Country Analysis; 11.7 China Market; 11.8 Summary; 11.9 Market Overview; 11.9.1 Country Information; 11.9.2 Market Information; 11.9.3 Background Information; 11.9.4 Government Initiatives; 11.9.5 Regulations; 11.9.6 Regulatory Bodies; 11.9.7 Major Associations; 11.9.8 Taxes Levied; 11.9.9 Corporate Tax Structure; 11.9.10 Investments; 11.9.11 Major Companies; 11.10 China Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.11 China Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.12 China Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.13 India Market; 11.14 India Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.15 India Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.16 India Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.17 Japan Market; 11.18 Summary; 11.19 Market Overview; 11.19.1 Country Information; 11.19.2 Market Information; 11.19.3 Background Information; 11.19.4 Government Initiatives; 11.19.5 Regulatory Bodies; 11.19.6 Major Associations; 11.19.7 Taxes Levied; 11.19.8 Corporate Tax Structure; 11.19.9 Investments; 11.19.10 Major Companies; 11.20 Japan Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.21 Japan Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.22 Japan Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.23 Australia Market; 11.24 Australia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.25 Australia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.26 Australia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.27 Indonesia Market; 11.28 Indonesia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.29 Indonesia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.30 Indonesia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.31 South Korea Market; 11.32 Summary; 11.33 Market Overview; 11.33.1 Country Information; 11.33.2 Market Information; 11.33.3 Background Information; 11.33.4 Government Initiatives; 11.33.5 Regulations; 11.33.6 Regulatory Bodies; 11.33.7 Major Associations; 11.33.8 Taxes Levied; 11.33.9 Corporate Tax Structure; 11.33.10 Investments; 11.33.11 Major Companies; 11.34 South Korea Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.35 South Korea Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.36 South Korea Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate tax structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Western Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.4 Western Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.5 Western Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.6 Western Europe Pneumococcal Vaccine Market: Country Analysis; 12.7 UK Market; 12.8 UK Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.9 UK Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.10 UK Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.11 Germany Market; 12.12 Germany Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.13 Germany Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.14 Germany Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.15 France Market; 12.16 France Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.17 France Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.18 France Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.19 Italy Market; 12.20 Italy Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.21 Italy Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.22 Italy Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.23 Spain Market; 12.24 Spain Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.25 Spain Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.26 Spain Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate Tax Structure; 13.2.10 Investments; 13.2.11 Major Companies; 13.3 Eastern Europe Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.4 Eastern Europe Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.5 Eastern Europe Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.6 Eastern Europe Pneumococcal Vaccine Market: Country Analysis; 13.7 Russia Market; 13.8 Russia Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.9 Russia Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.10 Russia Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major Companies; 14.3 North America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.4 North America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.5 North America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.6 North America Pneumococcal Vaccine Market: Country Analysis; 14.7 USA Market; 14.8 Summary; 14.9 Market Overview; 14.9.1 Country Information; 14.9.2 Market Information; 14.9.3 Background Information; 14.9.4 Government Initiatives; 14.9.5 Regulations; 14.9.6 Regulatory Bodies; 14.9.7 Major Associations; 14.9.8 Taxes Levied; 14.9.9 Corporate Tax Structure; 14.9.10 Investments; 14.9.11 Major Companies; 14.10 USA Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.11 USA Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.12 USA Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.13 Canada Market; 14.14 Summary; 14.15 Market Overview; 14.15.1 Country Information; 14.15.2 Market Information; 14.15.3 Background Information; 14.15.4 Government Initiatives; 14.15.5 Regulations; 14.15.6 Regulatory Bodies; 14.15.7 Major Associations; 14.15.8 Taxes Levied; 14.15.9 Corporate Tax Structure; 14.15.10 Investments; 14.15.11 Major Companies; 14.16 Canada Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.17 Canada Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.18 Canada Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Investments; 15.2.11 Major Companies; 15.3 South America Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.4 South America Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.5 South America Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.6 South America Pneumococcal Vaccine Market: Country Analysis; 15.7 Brazil Market; 15.8 Brazil Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.9 Brazil Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.10 Brazil Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Investments; 16.2.11 Major Companies; 16.3 Middle East Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.4 Middle East Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.5 Middle East Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Investments; 17.2.11 Major Companies; 17.3 Africa Pneumococcal Vaccine Market, Segmentation By Product Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.4 Africa Pneumococcal Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.5 Africa Pneumococcal Vaccine Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles: 18.1 Company Profiles; 18.2 Pfizer Inc; 18.2.1 Company Overview; 18.2.2 Products And Services; 18.2.3 Business Strategy; 18.2.4 Financial Overview; 18.3 Merck & Co., Inc.; 18.3.1 Company Overview; 18.3.2 Products And Services; 18.3.3 Business Strategy; 18.3.4 Financial Overview; 18.4 GlaxoSmithKline plc; 18.4.1 Company Overview; 18.4.2 Products And Services; 18.4.3 Financial Overview; 18.5 Serum Institute of India Pvt. Ltd; 18.5.1 Company Overview; 18.5.2 Products And Services; 18.5.3 Business Strategy; 18.5.4 Financial Overview; 18.6 Walvax Biotechnology Co. Ltd; 18.6.1 Company Overview; 18.6.2 Products And Services; 18.6.3 Financial Overview
19 Other Major And Innovative Companies: 19.1 Biological E. Limited; 19.1.1 Company Overview; 19.1.2 Products And Services; 19.2 Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.3 Shenzhen Kangtai Biological Products Co. Ltd. (Beijing Minhai Biotechnology Corporation Limited); 19.3.1 Company Overview; 19.3.2 Products And Services; 19.4 NPO Petrovax Pharm LLC; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.5 SK Bioscience Co. Ltd.; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.6 Vaxcyte, Inc.; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.7 Sinovac Biotech Ltd.; 19.7.1 Company Overview; 19.7.2 Products And Services; 19.8 Astellas Pharma Inc.; 19.8.1 Company Overview; 19.8.2 Products And Services; 19.9 LG Chem Ltd.; 19.9.1 Company Overview; 19.9.2 Products And Services; 19.10 AIM Vaccine Co. Ltd.; 19.10.1 Company Overview; 19.10.2 Products And Services; 19.11 Panacea Biotec Limited; 19.11.1 Company Overview; 19.11.2 Products And Services; 19.12 China National Biotec Group (CNBG); 19.12.1 Company Overview; 19.12.2 Products And Services; 19.13 Inventprise LLC; 19.13.1 Company Overview; 19.13.2 Products And Services; 19.14 Pnuvax Incorporated; 19.14.1 Company Overview; 19.14.2 Products And Services; 19.15 Tergene Biotech Private Limited; 19.15.1 Company Overview; 19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions: 22.1 SK bioscience Co. Ltd Acquired Fina Biosolutions; 22.2 GSK Plc Acquired Affinivax
23 Recent Developments In The Pneumococcal Vaccine Market: 23.1 New Pneumococcal Vaccine Launch Targets Nationwide Adult Protection; 23.2 Next-Generation Pneumococcal Vaccine Approval Targets Drug-Resistant Strains
24 Opportunities And Strategies: 24.1 Pneumococcal Vaccine Market In 2029 – Countries Offering Most New Opportunities; 24.2 Pneumococcal Vaccine Market In 2029 – Segments Offering Most New Opportunities; 24.3 Pneumococcal Vaccine Market In 2029 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Pneumococcal Vaccine Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates

Single User Online Download $4,490
Global Site License Online Download $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now